Ligand Pharmaceuticals, Inc. (LGND)
197.85
+1.79
(+0.91%)
USD |
NASDAQ |
Feb 27, 16:00
198.26
+0.42
(+0.21%)
After-Hours: 20:00
Ligand Pharmaceuticals Research and Development Expense (TTM) : 81.18M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Johnson & Johnson | 14.72B |
| Merck & Co., Inc. | 12.71B |
| ADMA Biologics, Inc. | 4.761M |
| Elanco Animal Health, Inc. | 368.00M |
| Ionis Pharmaceuticals, Inc. | 914.12M |